Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report) released its quarterly earnings data on Thursday. Zentalis Pharmaceuticals Price PerformanceShares of Zentalis Pharmaceuticals stock traded up $0.05 during trading on Thursday, hitting $5.00. Zentalis Pharmaceuticals has a 12 month low of $1.21 and a 12 month high of $6.95. Zentalis Pharmaceuticals Company Profile(Get Free Report)Zentalis Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for oncology. Further ReadingReceive News & Ratings for Zentalis Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentalis Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.